Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2010-06-09 Director's Dealing
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
Director's Dealing 2010
Director's Dealing
2010-06-09 English
Annual Report 2010
Annual Report FY 2010
2010-06-08 English
Earnings Release 2010
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 3, 2010. It announces the issuance of a press release containing financial results for the fiscal quarter and year ended March 31, 2010. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as an exhibit. The length is only 2265 characters, which is short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the full earnings release itself. Therefore, the document is best classified as an Earnings Release (ER) since it announces quarterly and annual financial results via a press release.
2010-06-03 English
Capital/Financing Update 2010
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 1, 2010, reporting the entry into a material definitive agreement involving a loan and security agreement and issuance of warrants. The content focuses on financing activities, including loan terms, interest rates, and warrants issued. There are no financial statements or comprehensive financial performance data presented, only details about the financing transaction. This fits the definition of a Capital/Financing Update (CAP) rather than an Annual Report, Earnings Release, or other categories. The document length is over 6,000 characters and contains substantive detail about the financing arrangement, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2010-05-06 English
Board/Management Information 2010
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses the granting of a one-time cash bonus to the Chairman and CEO, which is a change in compensatory arrangements for a senior officer. This fits the category of Board/Management Information (MANG), as it relates to management changes or announcements. The document is short (2542 characters) and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a certification or regulatory filing of a different nature, nor is it a report publication announcement. Therefore, the best classification is MANG with high confidence.
2010-04-02 English
FORM 4 SUBMISSION
Director's Dealing
2010-03-11 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.